Comerica Bank Zai Lab LTD Transaction History

Comerica Bank

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 18, 2022	SELL	$54.9 - $105.21 $478,892 - $917,746	-8,723 Closed	0 $0
Q3 2021 Nov 22, 2021	BUY	$105.0 - $178.37 $276,570 - $469,826	2,634 Added 43.26%	8,723 $919,000
Q2 2021 Aug 26, 2021	BUY	$125.11 - $180.0 $25,022 - $36,000	200 Added 3.4%	6,089 $1.08 Million
Q1 2021 Apr 28, 2021	BUY	$126.27 - $191.71 $24,117 - $36,616	191 Added 3.35%	5,889 $785,000
Q4 2020 Jan 28, 2021	BUY	$81.94 - $135.34 $90,543 - $149,550	1,105 Added 24.06%	5,698 $771,000
Q3 2020 Oct 30, 2020	SELL	$73.3 - $89.48 $5,424 - $6,621	-74 Reduced 1.59%	4,593 $381,000
Q2 2020 Jul 31, 2020	BUY	$48.82 - $82.53 $23,921 - $40,439	490 Added 11.73%	4,667 $383,000
Q1 2020 May 01, 2020	BUY	$39.1 - $62.9 $163,320 - $262,733	4,177 New	4,177 $215,000

121

46.7M

223K

588K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.64B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Comerica Bank, based on Form 13F filings with the SEC.

Stay updated on Comerica Bank with notifications on news.